Literature DB >> 12682291

A silent bomb: the risk of anthrax as a weapon of mass destruction.

G F Webb1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12682291      PMCID： PMC153555          DOI： 10.1073/pnas.0830963100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  Attacking anthrax.

Authors:  John A T Young; John R Collier
Journal:  Sci Am       Date:  2002-03       Impact factor: 2.142

2.  Into the jaguar's den.

Authors:  E Niiler
Journal:  Sci Am       Date:  2001-09       Impact factor: 2.142

3.  Emergency response to an anthrax attack.

Authors:  Lawrence M Wein; David L Craft; Edward H Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-21       Impact factor: 11.205

Review 4.  Anthrax as a biological weapon, 2002: updated recommendations for management.

Authors:  Thomas V Inglesby; Tara O'Toole; Donald A Henderson; John G Bartlett; Michael S Ascher; Edward Eitzen; Arthur M Friedlander; Julie Gerberding; Jerome Hauer; James Hughes; Joseph McDade; Michael T Osterholm; Gerald Parker; Trish M Perl; Philip K Russell; Kevin Tonat
Journal:  JAMA       Date:  2002-05-01       Impact factor: 56.272

5.  Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.

Authors:  Daniel B Jernigan; Pratima L Raghunathan; Beth P Bell; Ross Brechner; Eddy A Bresnitz; Jay C Butler; Marty Cetron; Mitch Cohen; Timothy Doyle; Marc Fischer; Carolyn Greene; Kevin S Griffith; Jeannette Guarner; James L Hadler; James A Hayslett; Richard Meyer; Lyle R Petersen; Michael Phillips; Robert Pinner; Tanja Popovic; Conrad P Quinn; Jennita Reefhuis; Dori Reissman; Nancy Rosenstein; Anne Schuchat; Wun-Ju Shieh; Larry Siegal; David L Swerdlow; Fred C Tenover; Marc Traeger; John W Ward; Isaac Weisfuse; Steven Wiersma; Kevin Yeskey; Sherif Zaki; David A Ashford; Bradley A Perkins; Steve Ostroff; James Hughes; David Fleming; Jeffrey P Koplan; Julie L Gerberding
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883
  5 in total
  8 in total

1.  Forensic application of microbiological culture analysis to identify mail intentionally contaminated with Bacillus anthracis spores.

Authors:  Douglas J Beecher
Journal:  Appl Environ Microbiol       Date:  2006-08       Impact factor: 4.792

2.  Endolysins of Bacillus anthracis bacteriophages recognize unique carbohydrate epitopes of vegetative cell wall polysaccharides with high affinity and selectivity.

Authors:  Kai-For Mo; Xiuru Li; Huiqing Li; Lieh Yoon Low; Conrad P Quinn; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2012-09-11       Impact factor: 15.419

3.  Modeling the host response to inhalation anthrax.

Authors:  Judy Day; Avner Friedman; Larry S Schlesinger
Journal:  J Theor Biol       Date:  2011-02-03       Impact factor: 2.691

4.  Chemical synthesis and immunological properties of oligosaccharides derived from the vegetative cell wall of Bacillus anthracis.

Authors:  Mahalakshmi Vasan; Jana Rauvolfova; Margreet A Wolfert; Christine Leoff; Elmar L Kannenberg; Conrad P Quinn; Russell W Carlson; Geert-Jan Boons
Journal:  Chembiochem       Date:  2008-07-21       Impact factor: 3.164

Review 5.  Anthrax vaccine and public health policy.

Authors:  Martin Meyer Weiss; Peter D Weiss; Joseph B Weiss
Journal:  Am J Public Health       Date:  2007-09-27       Impact factor: 9.308

6.  Mechanistic modeling of emergency events: assessing the impact of hypothetical releases of anthrax.

Authors:  S S Isukapalli; P J Lioy; P G Georgopoulos
Journal:  Risk Anal       Date:  2008-06       Impact factor: 4.000

7.  Quantitative models of the dose-response and time course of inhalational anthrax in humans.

Authors:  Damon J A Toth; Adi V Gundlapalli; Wiley A Schell; Kenneth Bulmahn; Thomas E Walton; Christopher W Woods; Catherine Coghill; Frank Gallegos; Matthew H Samore; Frederick R Adler
Journal:  PLoS Pathog       Date:  2013-08-15       Impact factor: 6.823

8.  Prioritizing risks and uncertainties from intentional release of selected Category A pathogens.

Authors:  Tao Hong; Patrick L Gurian; Yin Huang; Charles N Haas
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.